In case of T1D, another pathway might be involved: Inhibition of EHMT2 has been shown to enhance CTLA4 and FOXP3 expression in regulatory T cells (Ding et al., 2019), both are markers of regulatory T cell function needed to maintain tolerance and prevent autoimmunity. Here, EHMT2 is linked to type 1 diabetes mellitus.